Greg Dubé

Dr. Dubé has over 30 years of industry experience in drug R&D including leadership positions in large and small Pharma and biotech. Dr. Dubé is an expert in the physical, biochemical and pharmacological properties of HBOCs and has significant experience in the design and analysis of preclinical and clinical studies to evaluate them across a wide range of clinical indications, including donor organ perfusion, organ ischemia/reperfusion injury, hemorrhagic trauma/shock, anemia and heart failure. Dr. Dubé has a doctorate in pharmacology and cell biophysics from the University of Cincinnati College of Medicine and completed a postdoctoral fellowship at Duke University School of Medicine, Division of Cardiology.